skip to Global Navigation Bar
skip to main content
HOME
CONTACT US
SITEMAP
KOREAN
Global Business
Introduction
Strategy
Manufacturing
Contact Us
R&D
Introduction
Global R&D Centers
R&D Organization
Pipeline
CDMO
Introduction
Manufacturing Sites
Business Model
Service Range
Products
Global Brand
Products Search
In-License
Introduction
Strategy
No.1 Position
Core-Competency
Licensed Products
Partnership
Investors
Management information
Financial information
Stock condition
IR information
About Us
Company Profile
CEO Message
Recruitment
Press Release
Company Profile
CEO Message
Recruitment
Press Release
News
PR Video
Home > About Us > Press Release >
News
뉴스
No
Subject
Data
228
Daewoong Pharmaceutical’s anemia medication Epodion approved in Indonesia for January Launch
2017-01-05
227
Daewoong Pharmaceutical targeting 200 billion won overseas sales for Urusa by 2020… Effectively entering domestic and global markets
2016-12-22
226
Daewoong Pharmaceutical and Indonesia University collaborate to develop biopharmaceutical
2016-12-01
225
Daewoong Pharmaceuticals holds a symposium to promote the excellence of Olmesartan medications including ‘Olmetec’ at International Society of Hypertension
2016-09-28
224
Daewoong Pharmaceuticals expands entry to new markets with license in Mexico and India on Nabota
2016-09-22
223
Daewoong Pharmaceuticals disseminates the excellence of ‘Nabota’ in IMCAS
2016-08-02
222
Daewoong Pharmaceuticals signs 29 billion won export contract with Jordan and Iraq
2016-06-30
221
Seoul National University Hospital ? Daewoong Pharmaceuticals sign MOU to commercialize stem cell treatment
2016-06-28
220
Daewoong Pharmaceuticals presents result of phase 3 clinical trial on Supect at The Korean Society of Hematology
2016-05-31
219
Daewoong Pharmaceuticals receives Prime Minister Commendation as an ‘Outstanding Company in Fair Gender Employment’
2016-05-26
1
/
2
/
3
/
4
/
5
/
6
/
7
/
8
/
9
/
10
/
News Search
subject
content
Home > About Us > Press Release > News
Home > About Us > Press Release > News